1.. Introduction
================

Non-Hodgkin lymphomas (NHL), a complex group of heterogeneous diseases of uncontrolled B- or T-cell proliferation with distinct clinical and histological features, accounts for approximately 90% of all malignancy lymphomas \[[@b1-ijms-15-07684]\]. Malignant transformation of B- or T-cells can occur at different stages of maturation, which reflects the heterogeneity of malignancies with various biologic and clinical behaviors. B-cell lymphomas (BCL) comprise 90% of NHL. Diffuse large B-cell lymphomas (DLBCL) and follicular lymphomas (FL) are the two major subtypes of BCL. Clinical outcome of NHL varies from subtype, diagnosis and response to treatment, however, prognosis of T-cell lymphoma (TCL) is usually worse than that of BCL. Etiology of NHL is still poorly understood, although epidemiological studies have shown that individuals with innate or acquired immune deficiencies, immunosuppression and infection are at increased risk of NHL \[[@b2-ijms-15-07684],[@b3-ijms-15-07684]\]. Recently, accumulating evidence has suggested that genetic variations such as single nucleotide polymorphisms (SNPs) are associated with NHL risk and survival \[[@b4-ijms-15-07684]--[@b9-ijms-15-07684]\]. Moreover, previous studies showing a 2- to 3-fold risk of NHL with a family history of hematological malignancies indicates that genetic factors might play a critical role in NHL pathogenesis \[[@b10-ijms-15-07684]--[@b12-ijms-15-07684]\].

Tumor necrosis factor-α (TNF-α) is one of the most important pro-inflammatory and tumor-related cytokines for its regulating immune response, inflammation, Th1/Th2 balance and lymphomagenesis \[[@b13-ijms-15-07684]\]. Increased serum values of TNF-α have been detected in autoimmune disease and many malignancies including lymphomas \[[@b14-ijms-15-07684]--[@b17-ijms-15-07684]\]. TNF-α-308G\>A (rs1800629) SNP has increased susceptibility to many kinds of tumors and autoimmune diseases, such as hepatocellular carcinoma, myeloma, lymphoma, ulcerative colitis, and Crohn's disease \[[@b18-ijms-15-07684]--[@b20-ijms-15-07684]\]. TNF-α-308A allele is associated with higher constitutive and inducible TNF-α expression by affecting a consensus binding site of a transcription factor named activator protein-2 (AP-2) \[[@b21-ijms-15-07684],[@b22-ijms-15-07684]\]. Studies using knockout mouse have supported that this cytokine could affect progression of BCL directly or indirectly \[[@b23-ijms-15-07684],[@b24-ijms-15-07684]\]. Although the TNF-α-308G\>A polymorphism has been widely assessed in association with NHL in different ethnicities, due to various sample sizes and genotyping methods, possibly because of NHL heterogeneity and other reasons, the results are still controversial.

In this study, we conducted the first comprehensive meta-analysis to test whether the TNF-α-308 polymorphism is associated with NHL overall risk or its subtypes, especially BCL, TCL, DLBCL, FL, chronic lymphocytic leukemia/small lymphocytic lymphomas (CLL/SLL), mantel cell lymphomas (MCL), mucosal-associated lymphomas (MALT), peripheral T-cell lymphomas (PTCL) and natural killer/T-cell lymphomas (NK/TCL). We also performed subgroup analysis by descent (Caucasians and Asians) to assess a possible factor that might influence the overall results. Therefore, this study might have more statistical power and increase precision to estimate association between TNF-α-308 polymorphism and its effect on NHL.

2.. Results and Discussion
==========================

2.1.. Eligible Studies
----------------------

In the initial screening for key words, 405 potential articles were identified in PubMed, Embase and Cochrane Library. After removing duplication, 321 articles were needed for further assessment. Among them, 293 were excluded because of inappropriate study design or control samples. Of the remaining 28 relevant articles, 8 articles were excluded for using the same patients. 2 articles were also excluded for their controls in concordance with Hardy-Weinberg equilibrium (HWE). With strict including criteria, the final pool of eligible articles consisted of 18 articles involving a total of 10,619 patients with NHL and 12,977 healthy controls. Because of the large sample size, Caucasians and Asians were considered as population stratification in this meta-analysis. [Table 1](#t1-ijms-15-07684){ref-type="table"} shows characteristics of eligible articles including ethnicity, genotyping method, number of cases and controls and NHL pathological types. In fact, at the primary data extraction, allele frequencies in all controls of one study, which performed by Skibola, did not fulfill HWE \[[@b25-ijms-15-07684]\]. This study is a meta- and pooled analysis adding more genotyping data to the initial pooled report \[[@b26-ijms-15-07684]\] to confirm the association between TNF/LTA polymorphism and NHL risk in Caucasian and Asian populations. For the new subjects (including Caucasians and Asians) not included in the initial report (all were Caucasians) \[[@b26-ijms-15-07684]\], allele frequency of TNF-α-308G\>A in controls met HWE (*p* = 0.916). But TNF-α-308G\>A in all controls in the initial report was not consistent with HWE (*p* = 0.0007). We analyzed the initial report composed of 8 subgroups comprehensively \[[@b26-ijms-15-07684]\]. Finally, we excluded data of EPILYMPH-Spain, University of California San Francisco and the NCI-SEER Seattle subgroup, in which controls did not fulfill HWE, and extracted data successfully. Since Skibola *et al.* \[[@b25-ijms-15-07684]\] conducted this large pooled analysis in TNF polymorphism on NHL risk in Caucasians and Asians, we separated this paper into two studies according to population. In addition, 13 studies were conducted on Caucasians \[[@b16-ijms-15-07684],[@b27-ijms-15-07684]--[@b38-ijms-15-07684]\], and 4 were on Asians \[[@b39-ijms-15-07684]--[@b42-ijms-15-07684]\]. Several genotyping methods were used, including allelic specific polymerase chain reaction (ASPCR), polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), polymerase chain reaction-solid-phase minisequencing (PCR-SPM), polymerase chain reaction-ligation detection reaction (PCR-LDR), TaqMan, Sequenom and sequencing.

2.2.. Quantitative Synthesis
----------------------------

Based on a large pooled sample size, we analyzed TNF-α-308G\>A polymorphism effects on risks of NHL, BCL, TCL and subtypes (DLBCL, FL, CLL/SLL, MCL, MALT, PTCL and NK/TCL) in additive model (A *vs.* G) which stratified by ethnicity (Caucasians and Asians). Results of meta-analysis and primary data extracted from studies are listed in [Tables 2](#t2-ijms-15-07684){ref-type="table"} and [3](#t3-ijms-15-07684){ref-type="table"}.

### 2.2.1.. TNF-α-308G\>A and NHL

Of the combined 10,619 patients with NHL and 12,977 controls, no risk association was observed in TNF-308G\>A polymorphism and NHL with significant heterogeneity between studies (OR = 1.06, 95% CI: 0.92--1.23, *p* = 0.413; I^2^ = 75.0%, *p*~het~ \< 0.001). In subgroup analysis based on population, significant associations were detected in Caucasian and Asian populations, respectively. In Caucasians with 7893 cases and 8447 controls, participants with TNF-308A allele had an increased NHL risk (OR = 1.22, 95% CI: 1.06--1.40, *p* = 0.007; I^2^ = 60.7%, *p*~het~ = 0.002). However, in Asians with 2726 cases and 4530 controls, decreased risk was observed (OR = 0.75, 95% CI: 0.66--0.86, *p* \< 0.001; I^2^ = 0.0%, *p*~het~ = 0.670). [Figure 1](#f1-ijms-15-07684){ref-type="fig"} shows the forest plot of the overall association between TNF-α-308G\>A polymorphism and NHL risk in additive model (A *vs.* G) stratified by ethnicity.

To evaluate the influence of each study on the pooled ORs in two subgroups, we deleted single study at a time to recalculate the influence of individual study for the outcome of the meta-analysis. The pooled ORs were stable and in an effective interval with statistical significant though the fixed-effect in additive model estimating before or after any single study deleted in each group (data not shown). These indicated that the results of this meta-analysis were reliable and had not been overly influenced by any one of studies.

We performed Begg's funnel plot and Egger's test to evaluate the publication bias of all included studies. [Figure 2](#f2-ijms-15-07684){ref-type="fig"} shows no evidence of obvious asymmetry in overall analysis for TNF-α-308G\>A polymorphism in additive model (*p*~Begg's~ = 0.529). Egger's test also suggested no significant publication bias existed in this meta-analysis (additive model, *p* = 0.780).

### 2.2.2.. TNF-α-308G\>A and B- or T-CL

Thirteen studies comprising a total of 20,064 participants (8092 cases with BCL and 11,972 controls) and 4 studies including 11,832 participants (1100 cases with TCL and 10,732 controls) were analyzed for an association between TNF-α-308G\>A polymorphism and BCL or TCL risk.

For BCL analysis, the pooled OR across all studies was not statistically significant (OR = 1.07, 95% CI: 0.91--1.26, *p* = 0.411; I^2^ = 74.4%, *p*~het~ \< 0.001). Increased risk was found in Caucasians (OR = 1.18, 95% CI: 1.03--1.34, *p* = 0.014; I^2^ = 44.6%, *p*~het~ = 0.054), decreased risk was detected in Asians (OR = 0.70, 95% CI: 0.52--0.94, *p* = 0.018; I^2^ = 41.9%, *p*~het~ = 0.189). In TCL analysis, TNF-308A associated with a higher NHL risk in Caucasians (OR = 1.20, 95% CI: 1.01--1.42, *p* = 0.040; I^2^ = 0.0%, *p*~het~ = 0.361).

### 2.2.3.. TNF-α-308G\>A and NHL Subtypes

For DLBCL, the most common NHL subtype, there were 3353 cases and 10,817 controls included in the analysis. Consistent with the results for all NHL, the TNF-α-308A allele was associated with an increased risk of DLBCL in Caucasians (OR = 1.21, 95% CI: 1.11--1.32, *p* \< 0.001; I^2^ = 0.0%, *p*~het~ = 0.491), but with a decreased risk in Asians (OR = 0.70, 95% CI: 0.57--0.86, *p* = 0.001; I^2^ = 0.0%, *p*~het~ = 0.908). The pooled OR was 0.97 (95% CI: 0.75--1.26, *p* = 0.840; I^2^ = 83.9%, *p*~het~ \< 0.001).

No associations were found in TNF-α-308G\>A polymorphism with FL, CLL/SLL, MCL, MALT, PTCL and NK/TCL in overall and each ethnic subgroup.

2.3.. Discussion
----------------

In the pooled analysis of 18 articles, we found TNF-α-308G\>A polymorphism to be significantly associated with NHL risk in Caucasians and Asians. We provided evidence that subjects with TNF-α-308A allele had an increased risk of NHL in Caucasians, and had a decreased risk in Asians. Similar results were confirmed in analyses of BCL and DLBCL. Further, the TNF-α-308A allele was positively associated with risks of TCL in Caucasians. Our study highlights the effect of TNF-α gene polymorphism on risks of NHL and its subtypes in different populations. These findings indicate a potential connection between constitutively higher TNF-α expression and pathogenesis of NHL.

TNF-α is a transmembrane protein and mainly produced by macrophages and is expressed at low levels in a wide variety of cells. TNF-α mediates its effects through TNF-α receptor 1 and 2 (TNFR1 and TNFR2) by ligand passing and signal transduction. TNFR1 has a death domain that could interact with TNF-α receptor-associated death domain (TRADD), sequentially recruiting proteins to induce caspase-3 activation for apoptosis. TRADD could also bind TNF receptor-associated factor 2 (TRAF2) to recruits proteins activating IKK, GCK, and RIP, which finally leads to the NF-κB, JNK, and MAPK pathway activation for anti-apoptosis and cell survival. Although TNFR2 lacks the death domain, it could also bind TRAF2 to active an anti-apoptosis pathway \[[@b13-ijms-15-07684],[@b43-ijms-15-07684]\]. Aberrant NF-κB activation is a hallmark of several lymphomas for promoting continuous lymphocyte proliferation, which is also directly linked to disease promotion \[[@b44-ijms-15-07684],[@b45-ijms-15-07684]\]. When cells are exposed to TNF-α, NF-κB pathway activation leads to the expression of many genes to cause chronic inflammation, which stimulates tumor growth. Dysregulated TNF-α contributes directly to the transformed state in many cancers, especially those of BCL \[[@b46-ijms-15-07684]\]. Collectively, TNF-α acting as an immunoregulatory cytokine builds a bridge between inflammation and cancer by activating many biological pathways including the nuclear factor-κB (NF-κB) pathway in promoting cell proliferation, survival, transformation, invasion and angiogenesis.

Previous studies suggest higher expression of TNF-α is associated with NHL risk at the time of diagnosis \[[@b14-ijms-15-07684]--[@b17-ijms-15-07684]\]. These studies do not contradict the results of TNF-α-308A allele inducing higher constitutively TNF-α expression associated with decreased NHL risk in Asians. With a heterogeneous malignancy and population diversity, we believe the level of constitutively TNF-α expression must play a different vital role at the step of NHL initiation in Caucasians and Asians, although the reasons for this have not been understood. Once a tumor forms, it secretes TNF-α to promote its survival, proliferation and metastasis. A subtype of TCL failing to express TNF-α and frequently with the TNF-α gene promoter methylated \[[@b47-ijms-15-07684]\] indicates that epigenetic changes might also influence NHL susceptibility together. Environmental, occupational exposure and pathogenic agent infection (such as Epstein-Barr virus and human T-cell leukemia virus-1) are the well-known risk factors for NHL \[[@b48-ijms-15-07684],[@b49-ijms-15-07684]\]. Therefore, genetic, epigenetic, tumor microenvironment, environment and their interaction could together contribute to NHL progression. Few studies about this kind of interaction relative to NHL susceptibility have been published. Due to insufficient data, our meta-analysis did not combine the effects of these factors in an association analysis between genetic variation and NHL risk. Much more precise investigations should be performed to clarify the true association of these types of interactions with polymorphism and NHL.

TNF-α and LT-α gene lie in the major histocompatibility complex class III, telemetric to the class II and centrometric to class I gene. Therefore, TNF-α being in linkage disequilibrium (LD) with these genes may also be linked to another region, haplotype or extended, that can influence NHL development \[[@b50-ijms-15-07684]\]. This meta-analysis only evaluated one SNP in the TNF-α gene, though it was not possible to analyze haplotypes with the present data. Further studies will be needed to pool data and analyze whether haplotypes comprising TNF-α-308G\>A and other SNPs are linked to NHL risk, and clarify their function concomitantly.

Because of relatively low incidence of NHL, sample sizes of some studies included in this analysis are very small. The major strength of this study is the larger pooled sample size involving a total of 10,619 patients with NHL and 12,977 healthy controls for association study, which would largely minimize the possibility of chance findings. In addition, patients in our study were all Caucasians or Asians, which would exclude the biased results due to population stratification.

In conclusion, we performed the first comprehensive meta-analysis involving 10,619 patients with NHL and 12,977 controls from 18 articles to evaluate the association between TNF-α-308G\>A polymorphism and NHL risk. Our study showed that TNF-α-308G\>A SNP in the promoter region of TNF-α gene is associated with NHL risk. In addition, TNF-α-308A increases risks of NHL, BCL, TCL and DLBCL in the Caucasian population; however, interestingly, it reduces risks of NHL, BCL and DLBCL in the Asian population. This association might be mediated by constitutive changes of TNF-α expression in individuals carrying the -308A allele, to induce inflammatory responses or the alternative pathway which be involved in NHL initiation and progression. Our meta-analysis emphasizes that genetic variation plays a crucial role in cancer; theTNF-α-308G\>A polymorphism might play a role in a specific subtype of NHL and its importance varies in different populations. Further studies should focus on the function of how variants affect NHL in different populations and the elucidation of the pathway involved which may eventually lead to a better understanding of tumorigenesis and contribute to the prevention of NHL.

3.. Experimental Section
========================

3.1.. Publication Search
------------------------

We carried out a search in three electronic databases PubMed, Embase and Cochrane Library to find relevant publications up to November 2013, using key words related to the TNF-α gene polymorphism in combination with various NHL subtypes \[[@b51-ijms-15-07684]\]. The search was limited to studies that had been conducted on human subjects and without language restriction. Reference lists of the retrieved articles, reviews and editorials were also screened to find all additional eligible studies.

3.2.. Inclusion Criteria
------------------------

Selection of studies had to meet the following criteria: (1) case-control studies, family or sibling pairs studies were excluded; (2) published in English; (3) subjects were limited to adult and without autoimmune diseases, studies with children were also excluded; (4) DNA was extracted from peripheral blood leukocytes; (5) study described the association between TNF-α-308 polymorphism and NHL risk; (6) sufficient data for estimating odds ratio (OR) and its corresponding 95% confidence interval (95% CI); (7) control group fulfilled HWE. When the same subject group occurred in more than one study, only the complete study was chosen to be included in this meta-analysis.

3.3.. Data Extraction
---------------------

An initial screening of title and abstract was performed for the first step, followed by further screening based on full-text review. Information was independently extracted from all eligible publications by two investigators (K.Z. and J.D.), including the first author, publication year, ethnicity, sample size, genotyping method, the number of each genotype in cases and controls. For studies with subjects of different ethnic groups and had sufficient information, we extracted data separately for each ethnicity. Disagreements were resolved through discussion.

3.4.. Statistical Analysis
--------------------------

We assessed the association between TNF-α-308G\>A polymorphism and NHL risk by crude ORs and 95% CIs in an additive model. Heterogeneity among studies was examined with I^2^ statistics. In this meta-analysis, I^2^ \> 50% was defined as heterogeneity. Fixed-effect model (Mantel-Haenszel method) was used to evaluate inter-study heterogeneity. If heterogeneity existed, random-effect model (DerSimonian-Laird method) was used. *Z* test was used to determine the pooled OR and 95% CI. Analyses were also conducted on the subgroups of studies based on ethnicity. The potential influence of publication bias was assessed using Begg's funnel plot and Egger's linear regression test \[[@b52-ijms-15-07684],[@b53-ijms-15-07684]\]. To evaluate the effect of one single study on overall risk of NHL, sensitivity analyses by excluding every study and recalculating ORs and 95% CI were conducted \[[@b54-ijms-15-07684]\]. HWE in controls of each study was examined by the Pearson's goodness-of-fit χ^2^ test. All statistical tests were carried out with SPSS 16.0 (SPSS Inc., Chicago, IL, USA) and Stata 12.0 (StataCorp, College Station, TX, USA). A 2-tailed *p* \< 0.05 was considered as statistical significance.

4.. Conclusions
===============

We performed the first comprehensive meta-analysis involving 10,619 patients with NHL and 12,977 controls from 18 articles to evaluate the association between TNF-α-308G\>A polymorphism and NHL risk. Our study showed that TNF-α-308G\>A SNP in the promoter region of TNF-α gene is associated with NHL risk. In addition, TNF-α-308A increases risks of NHL, BCL, TCL and DLBCL in the Caucasian population; interestingly, this polymorhism reduces risks of NHL, BCL and DLBCL in the Asian population. This association might be mediated by constitutive changes of TNF-α expression in individuals carrying the -308A allele, to induce inflammatory responses or the alternative pathway which be involved in NHL initiation and progression. Our meta-analysis emphasizes that genetic variation plays a crucial role in cancer; the TNF-α-308G\>A polymorphism might play a role in a specific subtype of NHL and its importance may vary in different populations. Further studies should be focused on how variants affect NHL in different populations and the elucidation of the pathways involved which may eventually lead to a better understanding of tumorigenesis and contribute to the prevention of NHL.
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###### 

Characteristics of 18 eligible articles included in this meta-analysis.

  Study                      Ethnicity            Genotyping Method          Samples   Characteristics   
  -------------------------- -------------------- -------------------------- --------- ----------------- --------------
  Chouchane, 1997            Caucasians           ASPCR                      44        106               All subtypes
  Demeter, 1997              Caucasians           PCR-RFLP                   63        117               HCL only
  Warzocha, 1998             Caucasians           ASPCR                      273       96                All subtypes
  Fitzgibbon, 1999           Caucasians           PCR-RFLP                   121       88                FL only
  Wihlborg, 1999             Caucasians           PCR-SPM                    49        51                CLL only
  Mainou-Fowler, 2000        Caucasians           PCR-RFLP                   76        40                CLL
  Juszczynski, 2002          Caucasians           Sequencing                 204       120               All subtypes
  Hellmig, 2005              Caucasians           TaqMan                     138       533               MALT only
  Bel Hadj Jrad, 2007        Caucasians           PCR-RFLP                   194       160               All subtypes
  Jevtovic-Stoimenov, 2008   Caucasians           PCR-RFLP                   80        34                All subtypes
  Fernberg, 2010             Caucasians           Sequenom                   2267      1484              All subtypes
  Skibola, 2010              Caucasians, Asians   TaqMan or Pyrosequencing   4287      5591              All subtypes
  Xiao, 2011                 Asians               PCR-RFLP                   160       214               All subtypes
  Ibrahim, 2012              Caucasians           PCR-RFLP                   84        100               BCL only
  Hosgood, 2013              Asians               TaqMan                     291       300               All subtypes
  Lech-Maranda, 2013         Caucasians           TaqMan                     288       192               CLL only
  Liu, 2013                  Asians               PCR-LDR                    1932      3622              TCL only
  Nasira, 2013               Asians               PCR-RFLP                   68        129               All subtypes

Abbreviations: NHL, non-Hodgkin lymphomas; ASPCR, allelic specific polymerase chain reaction; PCR-RFLP, polymerase chain reaction-restriction fragment length polymorphism; PCR-SPM, polymerase chain reaction-solid-phase minisequencing; PCR-LDR, polymerase chain reaction-ligation detection reaction; HCL, hairy cell leukemias; FL, follicular lymphomas; CLL, chronic lymphocytic leukemias; MALT, mucosal-associated lymphomas; BCL, B-cell lymphomas; TCL, T-cell lymphomas.

###### 

Stratified analyses of TNF-α-308G/A polymorphism on NHL risk in Caucasians and Asians [\*](#tfn2-ijms-15-07684){ref-type="table-fn"}.

  Type      Ethnicity    Study (n)   Samples   OR (95% CI)         *p*                 I^2^ (%)   *p*~het~   
  --------- ------------ ----------- --------- ------------------- ------------------- ---------- ---------- -------
  NHL       Caucasians   14          7893      8447                1.22 (1.06--1.40)   0.007      60.7       0.002
  Asians    5            2726        4530      0.75 (0.66--0.86)   \<0.001             0.0        0.670      
  Overall   19           10,619      12,977    1.06 (0.92--1.23)   0.413               75.0       \<0.001    
                                                                                                             
  BCL       Caucasians   11          6369      8085                1.18 (1.03--1.34)   0.014      44.6       0.054
  Asians    2            1723        3887      0.70 (0.52--0.94)   0.018               41.9       0.189      
  Overall   13           8092        11,972    1.07 (0.91--1.26)   0.411               74.4       \<0.001    
                                                                                                             
  TCL       Caucasians   2           467       6810                1.20 (1.01--1.42)   0.040      0.0        0.361
  Asians    2            633         3922      0.96 (0.74--1.23)   0.723               57.8       0.124      
  Overall   4            1100        10,732    1.11 (0.96--1.28)   0.145               43.1       0.153      
                                                                                                             
  DLBCL     Caucasians   3           2325      6930                1.21 (1.11--1.32)   \<0.001    0.0        0.491
  Asians    2            1028        3887      0.70 (0.57--0.86)   0.001               0.0        0.908      
  Overall   5            3353        10,817    0.97 (0.75--1.26)   0.840               83.9       \<0.001    
                                                                                                             
  FL        Caucasians   3           1233      6898                1.00 (0.89--1.13)   0.949      31.0       0.235
  Asians    2            184         3887      0.72 (0.47--1.12)   0.142               12.4       0.285      
  Overall   5            1417        10,785    0.98 (0.87--1.10)   0.706               32.3       0.206      
                                                                                                             
  CLL/SLL   Caucasians   6           1859      7127                1.02 (0.92--1.13)   0.767      13.8       0.326
                                                                                                             
  MCL       Caucasians   2           250       6810                1.25 (1.00--1.57)   0.052      0.0        0.560
                                                                                                             
  MALT      Caucasians   1           138       533                 1.07 (0.76--1.51)   0.689                 
                                                                                                             
  PTCL      Caucasians   1           183       5326                1.11 (0.85--1.47)   0.446                 
  Asians    1            79          300       0.65 (0.29--1.48)   0.303                                     
  Overall   2            262         5636      1.05 (0.80--1.36)   0.741               32.9       0.222      
                                                                                                             
  NK/TCL    Asians       2           190       3922                0.74 (0.46--1.17)   0.196      12.4       0.285

Fixed-effect model was used when *p* value for heterogeneity test \>0.05; otherwise, random-effect model was used;

Abbreviations: TNF, tumor necrosis factor; NHL, non-Hodgkin lymphomas; BCL, B-cell lymphomas; TCL, T-cell lymphomas; DLBCL, diffuse large B-cell lymphomas; FL, follicular lymphomas; CLL/SLL, chronic lymphocytic leukemias/small lymphocytic lymphomas; MCL, mantel cell lymphomas; MALT, mucosal-associated lymphomas; PTCL, peripheral T-cell lymphomas; NK/TCL, natural killer/T-cell lymphomas.

###### 

Summary of primary data from eligible studies in this meta-analysis.

  Type                       Ethnicity       Study              Cases   Controls                        
  -------------------------- --------------- ------------------ ------- ---------- ------ ------ ------ -----
  NHL                        Caucasians      Chouchane, 1997    11      33         0      72     33     1
  Demeter, 1997              42              18                 3       81         34     2             
  Warzocha, 1998             203             65                 5       69         24     3             
  Fitzgibbon, 1999           96              23                 2       64         22     2             
  Wihlborg, 1999             29              19                 1       37         14     0             
  Mainou-Fowler, 2000        50              23                 3       28         11     1             
  Juszczynski, 2002          151             49                 4       85         32     3             
  Hellmig, 2005              93              39                 6       360        160    13            
  Bel Hadj Jrad, 2007        120             59                 15      107        49     4             
  Jevtovic-Stoimenov, 2008   32              46                 2       19         14     1             
  Fernberg, 2010             1490            675                102     1007       431    46            
  Skibola, 2010              2712            1136               164     3791       1394   141           
  Ibrahim, 2012              41              21                 22      67         27     6             
  Lech-Maranda, 2013         213             67                 8       136        53     3             
                                                                                                        
  Asians                     Skibola, 2010   243                29      3          212    49     4      
  Xiao, 2011                 138             20                 2       174        35     5             
  Hosgood, 2013              1702            221                9       3091       506    25            
  Liu, 2013                  264             27                 0       260        40     0             
  Nasira, 2013               58              9                  1       105        22     2             
                                                                                                        
  BCL                        Caucasians      Demeter, 1997      42      18         3      81     34     2
  Fitzgibbon, 1999           96              23                 2       64         22     2             
  Wihlborg, 1999             29              19                 1       37         14     0             
  Mainou-Fowler, 2000        50              23                 3       28         11     1             
  Juszczynski, 2002          72              29                 3       85         32     3             
  Hellmig, 2005              93              39                 6       360        160    13            
  Jevtovic-Stoimenov, 2008   24              29                 2       19         14     1             
  Fernberg, 2010             1395            630                91      1007       431    46            
  Skibola, 2010              2221            915                139     3791       1394   141           
  Ibrahim, 2012              41              21                 22      67         27     6             
  Lech-Maranda, 2013         213             67                 8       136        53     3             
                                                                                                        
  BCL                        Asians          Skibola, 2010      194     23         2      212    49     4
  Hosgood, 2013              1332            164                8       3091       506    25            
                                                                                                        
  TCL                        Caucasians      Fernberg, 2010     95      45         11     1007   431    46
  Skibola, 2010              216             90                 10      3791       1394   141           
                                                                                                        
  Asians                     Hosgood, 2013   287                54      1          3091   506    25     
  Liu, 2013                  264             27                 0       260        40     0             
                                                                                                        
  DLBCL                      Caucasians      Fernberg, 2010     371     173        23     1007   431    46
  Juszczynski, 2002          72              29                 3       85         32     3             
  Skibola, 2010              1093            495                66      3791       1394   141           
                                                                                                        
  Asians                     Skibola, 2010   86                 11      2          212    49     4      
  Hosgood, 2013              829             97                 3       3091       506    25            
                                                                                                        
  FL                         Caucasians      Fitzgibbon, 1999   96      23         2      64     22     2
  Fernberg, 2010             297             115                12      1007       431    46            
  Skibola, 2010              489             167                32      3791       1394   141           
                                                                                                        
  Asians                     Skibola, 2010   48                 6       0          212    49     4      
  Hosgood, 2013              115             13                 2       3091       506    25            
                                                                                                        
  CLL/SLL                    Caucasians      Wihlborg, 1999     29      19         1      37     14     0
  Mainou-Fowler, 2000        50              23                 3       28         11     1             
  Jevtovic-Stoimenov, 2008   24              29                 2       19         14     1             
  Fernberg, 2010             373             171                24      1007       431    46            
  Skibola, 2010              605             193                25      3791       1394   141           
  Lech-Maranda, 2013         213             67                 8       136        53     3             
                                                                                                        
  MCL                        Caucasians      Fernberg, 2010     76      33         10     1007   431    46
  Skibola, 2010              90              35                 6       3791       1394   141           
                                                                                                        
  MALT                       Caucasians      Hellming, 2005     93      39         6      360    160    13
                                                                                                        
  PTCL                       Caucasians      Skibola, 2010      125     53         5      3791   1394   141
                                                                                                        
  Asians                     Liu, 2013       72                 7       0          260    40     0      
                                                                                                        
  NK/TCL                     Asians          Hosgood, 2013      89      14         0      3091   506    25
  Liu, 2013                  81              6                  0       260        40     0             

Abbreviations: NHL, non-Hodgkin lymphomas; BCL, B-cell lymphomas; TCL, T-cell lymphomas; DLBCL, diffuse large B-cell lymphomas; FL, follicular lymphomas; CLL/SLL, chronic lymphocytic leukemias/small lymphocytic lymphomas; MCL, mantle cell lymphomas; MALT, mucosal-associated lymphomas; PTCL, peripheral T-cell lymphomas; NK/TCL, NK/T-cell lymphomas.

[^1]: These authors contributed equally to this work.
